基于“厚肠理论”的粪菌移植干预肠黏膜生物屏障治疗溃疡性结肠炎的研究进展

Research progress on fecal microbiota transplantation intervening intestinal mucosal barrier for treatment of ulcerative colitis based on the "Houchang Theory"

  • 摘要: 溃疡性结肠炎(UC)是一种慢性自身免疫性疾病, 主要病理特征为肠黏膜生物屏障受损。肠道菌群中的有益菌对维持肠道功能至关重要。因此,清除有害菌、促进有益菌群再生,重建肠黏膜屏障,已成为UC治疗的关键策略。中医“厚肠理论”从“脂膜”结构阐释溃疡形成机制,通过辨证施治增厚脂膜,达到治疗UC的目的。该理论与现代医学重建肠黏膜屏障的理念相吻合。粪菌移植(FMT)作为中医“金汁”的转化产物,已证实对UC有显著疗效。本文基于中医“厚肠理论”,从肠黏膜生物屏障视角,探讨“金汁”FMT治疗UC的机制,以期为临床治疗提供新策略。

     

    Abstract: Ulcerative colitis (UC) is a chronic autoimmune disease characterized primarily by impaired intestinal mucosal barrier function. Beneficial bacteria in the intestinal flora are crucial for maintaining intestinal function. Therefore, eliminating harmful bacteria, promoting the regeneration of beneficial bacteria, and reconstructing the intestinal mucosal barrier have become key strategies in the treatment of UC. The traditional Chinese medicine (TCM) "Houchang Theory" elucidates the mechanism of ulcer formation from the perspective of the "Zhimo" (lipid membrane) structure and achieves the purpose of treating UC by thickening the "Zhimo" through syndrome differentiation and treatment. This theory is consistent with the modern medical concept of reconstructing the intestinal mucosal barrier. Fecal microbiota transplantation (FMT), as a transformed product of TCM "Jinzhi" (liquid feces), has been proven to have significant efficacy in the treatment of UC. Based on the TCM "Houchang Theory" and from the perspective of the intestinal mucosal barrier, this article explored the mechanism of "Jinzhi" FMT in the treatment of UC and provides new strategies for clinical treatment.

     

/

返回文章
返回